Thursday, 11 October 2007

Prostate treatment tied to three-fold increase in heart disease risk

Filed under:

A new study released this week suggested that prostate cancer patients in the midst of hormone treatment used to slow tumor growth may actually be hurting their hearts. As in, facing a 300 percent increase of dying from heart disease in the future.

The results come from the research team seeing a decline in testosterone levels which happens when androgen-deprivation therapy (ADT) is used to combat prostate cancer.

Unfortunately, that drop can provoke insulin resistance, which can cause a chain reaction leading to type 2 diabetes, weight gain and increases in 'bad' cholesterol. Collectively, these conditions comprise the effect known as "metabolic syndrome." This is strongly associated with heart problems.

No comments: